| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is making significant strides in product development, particularly with its GLP-1 weight-loss pill, orforglipron, which has shown impressive results in clinical trials. The company's focus on domestic production enhances innovation and patient accessibility through convenient oral administration. Additionally, a robust drug pipeline, including candidates like VERVE-102 and Retatrutide, indicates strong potential for growth in the pharmaceutical sector. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.2, and the negative at -0.2 on 2025-04-19. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (1.3) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-19 | 0%(0%) | 0 | 0% | 0.1 | 1.3 | -1 | |||||||
| 2025-04-18 | 0%(0%) | 0 | 0% | 0 | 1 | -1 | |||||||
| 2025-04-17 | 0%(0%) | 0 | 0% | -0.1 | 0.6 | -1 | |||||||
| 2025-04-16 | 0%(0%) | 0 | 0% | -0.1 | 0.2 | -1 | |||||||
| 2025-04-15 | 0%(0%) | 0 | 0% | -0.4 | -1.3 | -1 | |||||||
| 2025-04-14 | 0%(0%) | 0 | 0% | -0.2 | -0.2 | -1 | |||||||
| 2025-04-13 | 0%(0%) | 0 | 0% | -0.5 | -1.8 | -1 | |||||||
| 2025-04-12 | 0%(0%) | 0 | 0% | -0.4 | -1.3 | -1 | |||||||
| 2025-04-11 | 0%(0%) | 0 | 0% | -0.4 | -1.3 | -1 | |||||||
| 2025-04-10 | 0%(0%) | 0 | 0% | -0.4 | -1.5 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-05-19 17:07:27 The anticipation of soaring sales in the anti-obesity drug market indicates significant earnings potential for companies like Eli Lilly. |
| 2025-05-19 17:07:27 The rising obesity epidemic drives competition among pharmaceutical companies in the anti-obesity drug market, adding to urgency in development. |
| 2025-05-19 17:07:27 Analysts are bullish on companies involved in the anti-obesity drug market, reflecting a positive outlook for their financial performance. |
| 2025-05-19 17:07:27 The increasing obesity rates in the U.S. highlight a burgeoning market for anti-obesity drugs, showing positive potential for growth in this segment. |
| 2025-05-19 17:07:27 The uncertainty around tariffs imposed by the Trump administration is causing concern across various industries, indicating a trend of vulnerability. |